Seamon Matthew J, Fass Jennifer A, Maniscalco-Feichtl Maria, Abu-Shraie Nada A
College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA.
Am J Health Syst Pharm. 2007 May 15;64(10):1037-44. doi: 10.2146/ajhp060471.
The pharmacology, therapeutic uses, safety, drug-drug interactions, and drug-disease interactions of medical marijuana are reviewed, and the legal issues related to its use and the implications of medical marijuana for the pharmacist are presented.
Marijuana contains more than 460 active chemicals and over 60 unique cannabinoids. The legal landscape surrounding marijuana is surprisingly complex and unsettled. In the United States, 11 states and several municipalities have legalized medical marijuana. Another state provides legislation that allows patients to claim a defense of medical necessity. Nevertheless, patients using medical marijuana may never interact with a pharmacist. Marijuana is a Schedule I controlled substance and its use is illegal under federal law. Marijuana has a number of purported therapeutic uses with a broad range of supporting evidence. There are five general indications for medical marijuana: (1) severe nausea and vomiting associated with cancer chemotherapy or other causes, (2) weight loss associated with debilitating illnesses, including HIV infection and cancer, (3) spasticity secondary to neurologic diseases, such as multiple sclerosis, (4) pain syndromes, and (5) other uses, such as for glaucoma. Marijuana is associated with adverse psychiatric, cardiovascular, respiratory, and immunologic events. Moreover, marijuana may interact with a number of prescription drugs and concomitant disease states.
Several states have legalized the use of marijuana for chronic and debilitating medication conditions. Pharmacists need to understand the complex legal framework surrounding this issue so that they can protect themselves and better serve their patients.
综述医用大麻的药理学、治疗用途、安全性、药物相互作用以及药物与疾病的相互作用,并介绍与医用大麻使用相关的法律问题及其对药剂师的影响。
大麻含有460多种活性化学物质和60多种独特的大麻素。围绕大麻的法律环境出人意料地复杂且不稳定。在美国,11个州和几个城市已将医用大麻合法化。另一个州制定了允许患者以医疗必要性为由进行抗辩的法律。然而,使用医用大麻的患者可能永远不会与药剂师接触。大麻是附表I管制物质,根据联邦法律其使用是非法的。大麻有许多所谓的治疗用途,并有广泛的支持证据。医用大麻有五个一般适应症:(1)与癌症化疗或其他原因相关的严重恶心和呕吐,(2)与包括艾滋病毒感染和癌症在内的衰弱性疾病相关的体重减轻,(3)继发于神经系统疾病(如多发性硬化症)的痉挛,(4)疼痛综合征,以及(5)其他用途,如用于青光眼。大麻与不良的精神、心血管、呼吸和免疫事件有关。此外,大麻可能与多种处方药和伴随的疾病状态相互作用。
几个州已将大麻用于慢性和衰弱性病症的使用合法化。药剂师需要了解围绕这个问题的复杂法律框架,以便他们能够保护自己并更好地为患者服务。